Active — Not RecruitingNot Applicable

Role of CMR-FT in Assessment of HCM and Athlete's Heart.

Egypt50 participantsStarted 2024-12-15

Plain-language summary

Using cardiac MRI feature tracking to asses myocardial motion differences in athlete's heart and discovered hypertrophic cardiomyopathy patients to increase diagnostic accuracy of hypertrophic cardiomyopathy.

Who can participate

Age range20 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients suspected to be hypertrophic cardiomyopathy by echocardiography.. * Athletes and heavy workers,, healthy volunteers also included. Exclusion Criteria: * Patients with absolute or relative contraindications to magnetic resonance imaging (e.g intra-ocular metallic foreign body, claustrophobia, etc) or contra-indication to MRI contrast medium. * Clinical morbidities with absolute contraindication to anesthesia during the examination in un-cooperative patients where sedation is required.

What they're measuring

Use of cardiac MRI feature tracking in detection of myocardial deformation abnormalities and diagnostic confirmation and detection of hypertrophic cardiomyopathy.

Timeframe: 6months to 12 months

Trial details

NCT IDNCT06859827

SponsorSohag University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-11-15

View on ClinicalTrials.gov More Hypertrophic Cardiomyopathies trials